Pfizer

Pharmaceuticals
PFE
$ 27 0.56
Share price
$ 153 bn
Market Cap
$ 216 bn
Enterprise Value

Carbon footprint

6.2 Ton
GHG emissions per $ 1 mln investment
0.18x the weighted average for S&P 500
FY2020
How is this calculated?
-8.9%
YOY change in GHG emissions
Weaker than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Pfizer's GHG emissions (location-based) (Kt of CO2e)

Pfizer's carbon footprint

Pfizer reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 1,330 Kt (-130 /-8.9% y-o-y).

No public disclosure of Scope 3 emissions has been found for Pfizer at the moment.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Pfizer also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Pfizer Inc. commits to reduce absolute scope 1 and 2 GHG emissions 46% by 2030 from a 2019 base year. Pfizer Inc. commits to increase annual sourcing of renewable electricity from 9% in 2019 to 100% by 2030. Pfizer Inc. commits to reduce absolute scope 3 emissions 25% from business travel by 2025 from a 2019 base year. Pfizer Inc. commits to reduce absolute scope 3 emissions 10% from upstream transportation and distribution by 2025 from a 2019 base year. Pfizer Inc. also commits that 64% of its suppliers by spend covering purchased goods & services, will have science-based targets by 2025. *The target boundary includes biogenic emissions and removals from bioenergy feedstocks.

Company environmental metrics

Show more...